Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., . . . Lanza, R. (2015). Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: Follow-up of two open-label phase 1/2 studies. The Lancet (British edition), 385(9967), 509-516. https://doi.org/10.1016/S0140-6736(14)61376-3
Citace podle Chicago (17th ed.)Schwartz, Steven D., et al. "Human Embryonic Stem Cell-derived Retinal Pigment Epithelium in Patients with Age-related Macular Degeneration and Stargardt's Macular Dystrophy: Follow-up of Two Open-label Phase 1/2 Studies." The Lancet (British Edition) 385, no. 9967 (2015): 509-516. https://doi.org/10.1016/S0140-6736(14)61376-3.
Citace podle MLA (9th ed.)Schwartz, Steven D., et al. "Human Embryonic Stem Cell-derived Retinal Pigment Epithelium in Patients with Age-related Macular Degeneration and Stargardt's Macular Dystrophy: Follow-up of Two Open-label Phase 1/2 Studies." The Lancet (British Edition), vol. 385, no. 9967, 2015, pp. 509-516, https://doi.org/10.1016/S0140-6736(14)61376-3.